News Release
March 18, 2014
ß÷ßäÉçÇø Diabetes Research Receives a Big Boost
Launch of new ß÷ßäÉçÇø Diabetes Institute: Johnson & Johnson Diabetes Research Fund Call for Proposals
·¡»å³¾´Ç²Ô³Ù´Ç²Ô… The ß÷ßäÉçÇø Diabetes Institute at the ß÷ßäÉçÇø has announced a new collaboration with Janssen Inc. in Canada to advance early-stage technologies related to Type I and Type II diabetes. Janssen is part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
The Johnson & Johnson Diabetes Research Fund is a newly-created $600,000 partnership, funded between Janssen, the Government of ß÷ßäÉçÇø, and the ß÷ßäÉçÇø Diabetes Foundation. The three year competitive fund, administered by U of A's ß÷ßäÉçÇø Diabetes Institute, will support research in either Type I or Type II diabetes with a focus on novel, discovery research with a high potential for commercialization.
"ß÷ßäÉçÇø's decades-long commitment to diabetes research has brought ground-breaking discoveries and better quality of life for diabetes sufferers, " said Fred Horne, Minister of Health. "Working collaboratively with our innovation system, Campus ß÷ßäÉçÇø and across the public and private sectors, means we can move promising discoveries to the marketplace faster where they can help ß÷ßäÉçÇøns and people worldwide."
Through the collaboration, the ß÷ßäÉçÇø Diabetes Institute and technical experts from Johnson & Johnson Innovation Center in California will jointly identify several high-potential opportunities from medical researchers across ß÷ßäÉçÇø and award up to $50,000 for one (1) year including indirect costs from the Research Fund. All aspects of diabetes research are eligible to apply for funding. Proposals are expected to lead to further development of drugs, devices, cell therapies and processes that relate to the diagnosis, treatment and management of Type I or Type II diabetes.
"Advancing the care of people living with Type I or II diabetes is a priority for us," said Dr. Douglas Miller, dean of the Faculty of Medicine & Dentistry. "This collaboration of funding partners exemplifies the good will of the private, public and philanthropic organizations to work together to best serve patients. Only by scientists working together across ß÷ßäÉçÇø will we find better treatments."
Letters of Intent are currently being accepted and instructions can be found by visiting the ß÷ßäÉçÇø Diabetes Institute website: www.adi.ualberta.ca/researchfund.aspx. The first call for Letters of Intent closes on April 30, 2014.
Over 9 million Canadians currently live with either pre-diabetes or Type I or Type II diabetes, and this private-public partnership fund will accelerate the development and validation of healthcare technologies within ß÷ßäÉçÇø which is known for life-changing research in the causes, prevention, treatment and management of diabetes.
- 30 -
Media Contact(s):
|
Earl McKenzie Innovation & Advanced Education Government of ß÷ßäÉçÇø Tel: (780) 415-0891 Email: earl.mckenzie@gov.ab.ca |
Jo-anne Nugent Faculty of Medicine & Dentistry ß÷ßäÉçÇø Tel: (780) 492-9651 Email: jo-anne.nugent@ualberta.ca |
BACKGROUNDER
About ß÷ßäÉçÇø Innovation and Advanced Education
Education and entrepreneurship are cornerstones of the dynamic economy that ß÷ßäÉçÇøns continue to build through their knowledge, adaptability and entrepreneurial spirit. Toward that end, ß÷ßäÉçÇø Innovation and Advanced Education aligns economic development activities in the province with post-secondary education, entrepreneurship, industry training, research and innovation. ß÷ßäÉçÇø is a leader in Canada with the implementation of this unique, inclusive structure, which builds on existing links between government functions that contribute to a stronger, more robust economy. Please visit our website at: .
About ß÷ßäÉçÇø Diabetes Foundation
The ß÷ßäÉçÇø Diabetes Foundation is devoted to raising money for diabetes research. Through our fundraising efforts, we directly support scientific research which has yielded extremely positive results. To date the ß÷ßäÉçÇø Diabetes Foundation has raised over $11.8 million in support of cure-related diabetes research. For more information about the ß÷ßäÉçÇø Diabetes Foundation, please visit .
About ß÷ßäÉçÇø Diabetes Institute
The ß÷ßäÉçÇø Diabetes Institute (ADI) is a research facility dedicated to translating discovery science into health solutions for the prevention, treatment and cure of Type I and Type II diabetes. The ADI uses a multidisciplinary approach, bringing together leading researchers from diverse fields of expertise in a state-of-the-art facility on the ß÷ßäÉçÇø Campus. Please visit our website at www.adi.ualberta.ca for more information.